MetLife posts record adjusted EPS as group benefits underwriting runs ahead of target
MetLife reported Q3 2026 adjusted EPS of $2.85, a record, with group benefits segment earnings up 15% YoY to $523M. Sales rose 12% YoY, with strong underwriting results. Net income surged 187% to $2.4B, but this was largely due to derivative accounting. Adjusted ROE was 19.6%, and adjusted book value per share increased 5% to $59.41.
How this was made

The 30-second read
Why it matters
The earnings beat and improved underwriting margins provide a clear catalyst for short‑term price appreciation.
Market read
First‑report earnings with material numbers; likely to move MET stock and influence the broader insurance sector.
What to watch
Potential volatility from interest‑rate driven derivative gains/losses could affect future results.
Background
MetLife's Q3 2026 earnings release includes adjusted EPS record, strong group benefits underwriting, and guidance on mortality ratios.
Ticker impact
MetLife reported record adjusted EPS and strong group benefits underwriting results, beating prior expectations and providing new guidance.
likely upward pressure as market prices in the earnings beat and improved mortality ratios
The article presents first‑report earnings numbers, adjusted EPS record, and guidance that exceeds prior ranges, which are material new data for traders.
Market effects
Highlights strength in the U.S. insurance sector, especially group benefits underwriting.
Positive for U.S. financial services equities.
Reinforces confidence in large-cap insurers worldwide.
Counterpoint
If higher mortality ratios re‑emerge, earnings could soften, limiting upside.
Key entities
- companyMetLife
U.S. insurer reporting record adjusted EPS and strong underwriting performance.




